Cure My Disease

Don't miss your cure!

 Log in / Sign up

Timing of blood thinners after childbirth bleeding may prevent clots without causing more harm

NCT ID NCT07689136

Completed Knowledge-focused Sponsor: University Tunis El Manar Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study examines the best time to start blood thinners in women who have had severe bleeding after childbirth. Researchers are looking at whether starting blood thinners within 24 hours or later affects the risk of blood clots or further bleeding. The goal is to find a balance that protects mothers from dangerous clots without increasing bleeding complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Low Molecular Weight Heparin (LMWH) or Unfractionated Heparin (UFH)
What this could lead to
If successful, this could help doctors decide the safest time to start blood thinners after severe postpartum bleeding, reducing the risk of dangerous blood clots without increasing bleeding.
What could go wrong
This is a retrospective study, meaning it looks back at past records, so it cannot prove cause and effect. The results may not apply to all hospitals or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP VEIN THROMBOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Postpartum Hemorrhage pulmonary embolism Venous Thrombosis venous thromboembolism prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEEP VEIN THROMBOSIS POSTPARTUM HEMORRHAGE PULMONARY EMBOLISM VENOUS THROMBOEMBOLISM

Contacts and locations

Locations

  • Center of Maternity and Neonatology of Tunis (CMNT)

    Tunis, 1007, Tunisia

More trials for these conditions

Other studies related to the condition(s) this trial covers.